Saxenda (liraglutide) is a prescription-only injectable medication in the same class as Ozempic (semaglutide). However, unlike Ozempic, Saxenda is approved by the Food and Drug Administration (FDA) ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

The Therapeutic Goods Administration (TGA) has warned patients taking GLP-1 weight loss and diabetes jabs should be monitored for suicidal behaviour.

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication. It helps with sustained weight loss for adults with obesity, adults with overweight who are experiencing weight-related health issues ...

The World Health Organization has released new guidance on some weight loss medications for adults with obesity.

Weight loss jab could be used to slow progression of Alzheimer’s disease in major breakthrough - Liraglutide, sold under the ...

Brain scans in patients revealed the drug slowed brain volume loss by around half compared to the placebo. A weight-loss jab ...

Saxenda is a brand-name subcutaneous injection that doctors often prescribe to help some people lose weight. You should keep opened Saxenda pens in the refrigerator but dispose of them after 30 days.

A new study for the HSE has found that making the weight loss drug Mounjaro available to public patients would not be value ...

By Nancy Lapid (Reuters) -U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who ...